SANDRINE ASPESLAGH

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

Odrade Gondry, Catarina Xavier, Johannes Heemskerk, Laurens Albert J Raes, Jens Debacker (UGent) , Frank De Geeter, Christel Fontaine, Marian Vanhoeij, SANDRINE ASPESLAGH (UGent) , Sofie Joris, et al.

(2023) EMIM 2023, European Molecular Imaging Meeting, Abstracts.

Add to list

Journal Article
A1
open access

New paradigm in NKT cell antigens : MCS-0208 (2-(hydroxymethyl)phenylthio-phytoceramide) - an aryl-phytoceramide compound with a single hydroxyl group stimulates NKT cells

Roser Borras-Tuduri, Anna Alcaide, SANDRINE ASPESLAGH (UGent) , Lorena Usero, Carmen Serra, Carme Roura-Mir, Dirk Elewaut (UGent) and Amadeu Llebaria

(2021) CHEMMEDCHEM. 16(16). p.2491-2496

Add to list

Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma

Astrid De Meulenaere, Tijl Vermassen (UGent) , David Creytens (UGent) , SANDRINE ASPESLAGH (UGent) , Philippe Deron (UGent) , Fréderic Duprez (UGent) , Sylvie Rottey (UGent) , Jo Van Dorpe (UGent) and Liesbeth Ferdinande (UGent)

(2018) HISTOPATHOLOGY. 73(3). p.500-509

Add to list

Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck

Astrid De Meulenaere, Tijl Vermassen (UGent) , SANDRINE ASPESLAGH (UGent) , Wouter Huvenne (UGent) , Jo Van Dorpe (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2017) ORAL ONCOLOGY. 70. p.34-42

Add to list

Journal Article
A1
open access

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells : markers of improved prognosis in oropharyngeal cancer

Astrid De Meulenaere, Tijl Vermassen (UGent) , SANDRINE ASPESLAGH (UGent) , Philippe Deron (UGent) , Fréderic Duprez (UGent) , Debby Laukens (UGent) , Jo Van Dorpe (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2017) ONCOTARGET. 8(46). p.80443-80452

Add to list

TILs in head and neck cancer : ready for clinical implementation and why (not)?

Astrid De Meulenaere, Tijl Vermassen (UGent) , SANDRINE ASPESLAGH (UGent) , Katrien Vandecasteele (UGent) , Sylvie Rottey (UGent) and Liesbeth Ferdinande (UGent)

(2017) HEAD & NECK PATHOLOGY. 11(3). p.354-363

Add to list

Journal Article
A1
open access

Synthesis of C-5" and C-6"-modified α-GalCer analogues as iNKT-cell agonists

Joren Guillaume (UGent) , Nora Pauwels (UGent) , SANDRINE ASPESLAGH (UGent) , Dirk Zajonc (UGent) , Dirk Elewaut (UGent) and Serge Van Calenbergh (UGent)

(2015) BIOORGANIC & MEDICINAL CHEMISTRY. 23(13). p.3175-3182

Add to list

Journal Article
A1
open access

An in silico approach for modelling T-helper polarizing iNKT cell agonists

Anton De Spiegeleer (UGent) , Evelien Wynendaele (UGent) , Matthias Vandekerckhove, Sofie Stalmans (UGent) , Maxime Boucart, Nele Van Den Noortgate (UGent) , Koen Venken (UGent) , Serge Van Calenbergh (UGent) , SANDRINE ASPESLAGH (UGent) and Dirk Elewaut (UGent)

(2014) PLOS ONE. 9(1).

Add to list

Journal Article
A1
open access

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model

Haneen Nur, Karel Fostier, SANDRINE ASPESLAGH (UGent) , Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau (UGent) , Karine Breckpot, Rik Schots, Marc De Waele, et al.

(2013) PLOS ONE. 8(5).

Add to list

Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells

Koen Venken (UGent) , Tine Decruy (UGent) , SANDRINE ASPESLAGH (UGent) , Serge Van Calenbergh (UGent) , Bart Lambrecht (UGent) and Dirk Elewaut (UGent)

(2013) JOURNAL OF IMMUNOLOGY. 191(5). p.2174-2183

Academic Bibliography

SANDRINE ASPESLAGH

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

New paradigm in NKT cell antigens : MCS-0208 (2-(hydroxymethyl)phenylthio-phytoceramide) - an aryl-phytoceramide compound with a single hydroxyl group stimulates NKT cells

Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma

Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells : markers of improved prognosis in oropharyngeal cancer

TILs in head and neck cancer : ready for clinical implementation and why (not)?

Synthesis of C-5" and C-6"-modified α-GalCer analogues as iNKT-cell agonists

An in silico approach for modelling T-helper polarizing iNKT cell agonists

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model

Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells

Contents

Support

Contact